BIOCHEMICAL AND HISTOLOGICAL CHANGES IN REPRODUCTIVE ORGANS OF EXPERIMENTAL RATS AFTER DIENOGEST THERAPY
article
OA: diamond
CC0
Abstract
The precise method of action of dienogest on the production and development of endometriosis lesions is unknown, and its controversial effect on endometrial thickness has been under investigation.In the following study the Dienogest's effects on the target animal's histology of female reproductive organs, including the tissues from the Fallopian tubes, ovaries, and uterus, as well as the impact of drug administration on the liver's enzymes and the drug's effects on triglycerides, body weight, and HbA1c, have all been studied.The findings of the following experiment indicated that there was no significant elevation of liver enzymes.The little to no elevation of the liver enzymes indicated that the drug did not induce stress on the hepatic cells and according to the subsequent experiment it is safe for clinical use.Moreover, after 10, 20, and 30 days of blood administration, the level of blood TG significantly decreased, and after 30 days of intake, the level of blood sugar significantly decreased.However, there were no appreciable changes after 10 and 20 days.After 30 days of treatment, the rats' weight also showed a very minor drop.In addition to it, the results of histological changes in the tissue in the following study represented that there were evident changes in the tissues which comprised of decline in blood circulation, fibrosis in tissues, and degeneration of follicles.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (25)
- A progestin isn’t a progestin: dienogest for endometriosis as a blueprint for future research – Review as a contribution for discussion - via openalex
- Current and Future Medical Therapies for Adenomyosis via openalex
- Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what’s the best choice? via openalex
- Effectiveness of Dienogest for Treatment of Recurrent Endometriosis: Multicenter Data via openalex
- Effects of new generation progestins, including as mixtures and in combination with other classes of steroid hormones, on zebrafish early life stages via openalex
- Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment via openalex
- Germany Endometriosis Pattern Changes; Prevalence and Therapy over 2010 and 2019 Years: A Retrospective Cross-Sectional Study. via openalex
- Long-Term Administration of Dienogest for the Treatment of Pain and Intestinal Symptoms in Patients with Rectosigmoid Endometriosis via openalex
- Novel Medicine for Endometriosis and Its Therapeutic Effect in a Mouse Model via openalex
- Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment via openalex
- Study of dienogest clinical efficacy in the treatment of adenomyosis via openalex
- W3049721443 via openalex
- W2967611590 via openalex
- W2796429112 via openalex
- W3121664759 via openalex
- W2789820715 via openalex
- W3217698861 via openalex
- W4200179104 via openalex
- W4200356756 via openalex
- W4220757585 via openalex
- W4221111020 via openalex
- W4282586889 via openalex
- W2776845334 via openalex
- W3002734356 via openalex
- W6782038002 via openalex
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK